Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer

J Natl Cancer Inst. 2012 Jul 18;104(14):1107-9; author reply 1109-12. doi: 10.1093/jnci/djs279.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aging*
  • Cancer Vaccines / therapeutic use*
  • Humans
  • Immunotherapy / methods*
  • Male
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Prostatic Neoplasms / drug therapy*
  • Protein Tyrosine Phosphatases / metabolism*
  • Tissue Extracts / therapeutic use*

Substances

  • Cancer Vaccines
  • Tissue Extracts
  • Protein Tyrosine Phosphatases